You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾輝健康-B(6606.HK)漲超5% 發佈常衞清香港上市百日戰報
格隆匯 09-29 10:18
格隆匯9月29日丨醫藥類股集體上漲之際,諾輝健康跟漲,盤中漲超5%報14.88港元。諾輝健康日前發佈常衞清香港上市百日戰報,共銷售6000人/份,到檢逾2000人/份。目前在香港的合作渠道超過50家,其中包括醫思健康、快驗保、港怡醫院、香港聖德肋撒醫院(St. Teresa's)、 香港體檢、尚至醫院等。常衞清是目前唯一獲批國家藥品監督管理局的癌症早篩產品。常衞清專利技術多靶點糞便FIT-DNA技術也是目前唯一獲得3部結直腸癌篩查診療國家級指南的推薦。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account